CheckMate 9ER

Home Tag

Ok_elegida_por_ella

CheckMate 9ER: extended follow-up data further supports nivolumab plus cabozantinib as first-line treatment of advanced renal cell carcinoma

The phase III international CheckMate 9ER trial continues to make headlines. Now published ahead of print in The Lancet Oncology…

Ok_elegida_por_ella

VHIO co-led studies illuminate the value of biomarker analyses & point to a new treatment avenue for patients with renal cell carcinoma

Kidney cancer (KC) ranks 14th in the most common cancers with 431,288 cases in 2020 and an estimated 179,368 deaths…